제품 정보로 건너뛰기
1 1

Cloud-clone

SKU(재고 관리 코드):CEA632Hu

ELISA Kit for Pepsin (PP)

ELISA Kit for Pepsin (PP)

UOM
Sensitivity
Detection range

Enzyme-linked immunosorbent assay for Antigen Detection.

Product No.

CEA632Hu

Organism Species

Homo sapiens (Human).

Sample Type

serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids

Test Method

Competitive Inhibition

Assay Length

2h

Detection Range

2.47-200ng/mL

Sensitivity

The minimum detectable dose of this kit is typically less than 0.87ng/mL.

UOM

48T 96T 96T*5 96T*10 96T*100

 

Specificity

This assay has high sensitivity and excellent specificity for detection of Pepsin (PP).
No significant cross-reactivity or interference between Pepsin (PP) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Pepsin (PP) and the recovery rates were calculated by comparing the measured value to the expected amount of Pepsin (PP) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 93-102 97
EDTA plasma(n=5) 81-99 91
heparin plasma(n=5) 88-99 94

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Pepsin (PP) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Pepsin (PP) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Pepsin (PP) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 88-99% 92-105% 86-94% 78-101%
EDTA plasma(n=5) 83-97% 82-101% 86-99% 95-102%
heparin plasma(n=5) 97-105% 85-94% 97-104% 97-104%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 50µL standard or sample to each well.
    And then add 50µL prepared Detection Reagent A immediately.
    Shake and mix. Incubate 1 hour at 37°C;
3. Aspirate and wash 3 times;
4. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
5. Aspirate and wash 5 times;
6. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
7. Add 50µL Stop Solution. Read at 450 nm immediately.

Specificity

This assay has high sensitivity and excellent specificity for detection of Pepsin (PP).
No significant cross-reactivity or interference between Pepsin (PP) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Pepsin (PP) and the recovery rates were calculated by comparing the measured value to the expected amount of Pepsin (PP) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 93-102 97
EDTA plasma(n=5) 81-99 91
heparin plasma(n=5) 88-99 94

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Pepsin (PP) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Pepsin (PP) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Pepsin (PP) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 88-99% 92-105% 86-94% 78-101%
EDTA plasma(n=5) 83-97% 82-101% 86-99% 95-102%
heparin plasma(n=5) 97-105% 85-94% 97-104% 97-104%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 50µL standard or sample to each well.
    And then add 50µL prepared Detection Reagent A immediately.
    Shake and mix. Incubate 1 hour at 37°C;
3. Aspirate and wash 3 times;
4. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
5. Aspirate and wash 5 times;
6. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
7. Add 50µL Stop Solution. Read at 450 nm immediately.

Magazine Citations
Radiology and Oncology LEVEL OF PEPSIN AND BILE ACIDS IN THE SALIVA OF PATIENTS WITH GLOTTIS T1 CARCINOMA Szd:Source
Radiology and Oncology Higher levels of total pepsin and bile acids in the saliva as a possible risk factor for early laryngeal cancer Pubmed:Pmc4362607
Clin Otolaryngol Pepsin and bile acids in saliva in patients with laryngopharyngeal reflux – a prospective comparative study PubMed: 25516364
journal of pediatric gastroenterology and nutrition Does Positioning Affect Tracheal Aspiration of Gastric Content in Ventilated Infants? PubMed: 25313850
Journal of Voice Detecting Laryngopharyngeal Reflux by Immunohistochemistry of Pepsin in the Biopsies of Vocal Fold Leukoplakia pubmed:28756936
Sensors (Basel) Label-Free Detection of Salivary Pepsin Using Gold Nanoparticle/Polypyrrole Nanocoral Modified Screen-Printed Electrode Pubmed:29882917
The Tohoku Journal of Experimental Medicine Association between Pepsin in Bronchoalveolar Lavage Fluid and Prognosis of Chronic Fibrosing Interstitial Lung Disease
Respiratory Research Pulmonary aspiration in preschool children with cystic fibrosis Pubmed: 30558606
Tanaffos Association of Bile Acid and Pepsin Micro-aspiration with Chronic Obstructive Pulmonary Disease Exacerbation Pubmed: 31423141
Sensors Optimization of Saliva Collection and Immunochromatographic Detection of Salivary Pepsin for Point-of-Care Testing of Laryngopharyngeal Reflux Pubmed: 31935973
BIOSCIENCE REPORTS Presence of pepsin in laryngeal tissue and saliva in benign and malignant neoplasms Pubmed: 33103719
OTOLARYNGOLOGY-HEAD AND NECK SURGERY Relationship Between Pepsin Expression and Dysplasia Grade in Patients With Vocal Cord Leukoplakia Pubmed: 32692278
American Journal of Otolaryngology Association of pepsin and DNA damage in laryngopharyngeal reflux-related vocal fold polyps Pubmed: 32889371
The relationship between laryngopharyngeal reflux based on pepsin value and clinical characteristics of laryngeal cancer patients
Med Sci Monit The Role of Salivary Pepsin in the Diagnosis of Gastroesophageal Reflux Disease (GERD) Evaluated Using High-Resolution Manometry and 24-Hour?¡­ 33220027
Annals of Esophagus Pepsin properties, structure, and its accurate measurement: a narrative review
Laryngoscope The Impact of Laryngopharyngeal Reflux on Occurrence and Clinical Course of Recurrent Respiratory Papillomatosis 34338331
Pulmonology Bronchoalveolar lavage (BAL) amylase and pepsin levels as potential biomarkers of aspiration pneumonia Pubmed:35715334
Neuromodulation: Technology at the Neural Interface Transcutaneous Electrical Acustimulation Improved the Quality of Life in Patients With Diarrhea-Irritable Bowel Syndrome Pubmed:35088760
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
CPA632Hu21 OVA Conjugated Pepsin (PP) Immunogen; SDS-PAGE; WB.
CPA632Hu23 OVA Conjugated Pepsin (PP) Immunogen; SDS-PAGE; WB.
CPA632Hu22 OVA Conjugated Pepsin (PP) Immunogen; SDS-PAGE; WB.
PAA632Hu02 Polyclonal Antibody to Pepsin (PP) WB; IHC; ICC; IP.
PAA632Hu08 Polyclonal Antibody to Pepsin (PP) WB; IHC; ICC; IP.
PAA632Hu01 Polyclonal Antibody to Pepsin (PP) WB,IHC
PAA632Hu09 Polyclonal Antibody to Pepsin (PP) WB; IHC; ICC; IP.
LAA632Hu71 Biotin-Linked Polyclonal Antibody to Pepsin (PP) WB; IHC; ICC.
MAA632Hu22 Monoclonal Antibody to Pepsin (PP) WB; IHC; ICC; IP.
SEA632Hu ELISA Kit for Pepsin (PP) Enzyme-linked immunosorbent assay for Antigen Detection.
CEA632Hu ELISA Kit for Pepsin (PP) Enzyme-linked immunosorbent assay for Antigen Detection.
IEA632Hu Instant ELISA Kit for Pepsin (PP) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA632Hu Magnetic Luminex Assay Kit for Pepsin (PP) ,etc. Magnetic Luminex Assay for Antigen Detection.
KSA632Hu11 ELISA Kit DIY Materials for Pepsin (PP) Main materials for "Do It (ELISA Kit) Yourself".
전체 세부 정보 보기